Werbung
Werbung

BOLD

BOLD logo

Boundless Bio, Inc. Common Stock

1.31
USD
Gesponsert
+0.03
+2.19%
08. Jan., 16:00 UTC -5
Geschlossen
exchange

Vor-Markt

1.31

0.00
0.00%

BOLD Ergebnisberichte

Positives Überraschungsverhältnis

BOLD übertreffen die 4 der letzten 7Schätzungen.

57%

Nächster Bericht

Datum des nächsten Berichts
23. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.53
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
-14.52%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-28.38%

Boundless Bio, Inc. Common Stock earnings per share and revenue

On 05. Nov. 2025, BOLD reported earnings of -0.62 USD per share (EPS) for Q3 25, missing the estimate of -0.59 USD, resulting in a -4.34% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.53 USD, with revenue projected to reach -- USD, implying an decrease of -14.52% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Boundless Bio, Inc. Common Stock reported EPS of -$0.62, missing estimates by -4.34%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.08%, changed from $1.30 before the earnings release to $1.26 the day after.
The next earning report is scheduled for 23. März 2026.
Based on 5 analysts, Boundless Bio, Inc. Common Stock is expected to report EPS of -$0.53 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung